Search

everythinglearnresearchcommunity

for

Search:↓

LTBP1 is a key regulator in diseases and a potential target for new treatments.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Targeting LPA could help treat skin disorders.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Adipose tissue-derived exosomes may help treat lichen planopilaris and preserve hair.

Lychnophora salicifolia extract in liposomes may protect skin from UV damage and inflammation.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Different sPLA2 enzymes have unique roles in phospholipid metabolism and biological processes.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

FOL-026 peptide can help repair blood vessels and promote growth, offering potential treatment for vascular diseases.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Phospholipids from pig lungs can significantly promote hair growth.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

Lidocaine-loaded microparticles effectively relieve pain and fight bacteria in wounds.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Lychee fruit polyphenol (Oligonol®) may regulate genes linked to cell growth and inflammation in human scalp cells.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

A new liposome treatment helps heal deep burns on mice by improving hair regrowth and reducing scarring.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

People with lichen planus have higher bad cholesterol and lower good cholesterol, increasing their risk for heart disease.

Careful management of blood thinners is crucial for lupus patients with APS.